On that measure, the government is spending about 30% more this year than it did pre-COVID. Forget the unexpected COVID expenditures. You've mentioned $52 billion net. The number's much higher. The government is classifying this spending plan as fiscal restraint. In this spending, there is no additional spending for pharmacare or for new health transfers to provinces.
First, would you characterize a 30% increase in spending as restrained spending growth? Second, have you done any analysis on additional spending pressures and what that might do to the spending on a go-forward basis?